RHÃN-KLINIKUM AG 22.12.2014 15:34 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification pursuant to sec. 26 para. 1 of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG) Dr. Ulrich Wandschneider (CEO) and Dipl.-Kfm. Stephan Leonhard (Deputy CEO, CFO) notified us for and on behalf of Dr. Bernard gr. Broermann, business domicile at Debusweg 3, 61462 Königstein-Falkenstein and Asklepios Kliniken GmbH, Debusweg 3, 61462 Königstein-Falkenstein, Deutschland (the aforementioned persons are collectively named the 'Notifying Persons' hereafter) of the following on 18 December 2014: The Notifying Persons are referring to their notifications according to sec. 21 and 22 of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG) concerning RHÃN-KLINIKUM Aktiengesellschaft ('Corporation') of 21 November 2014. With respect to the objectives pursued with the acquisition of the voting rights, the Notifying Persons have informed us according to Section 27a para 1 sentence 1 and 3 of the German Securities Trading Act, that: 1. The Notifying Persons consider the holding in the corporation as a long-term strategic investment. 2. The Notifying Persons are eventually willing to obtain further voting rights by acquisition or any other way within the next 12 month - depending on the share price and the general performance of the corporation. 3. The Notifying Persons intend to obtain an appropriate representation on the supervisory board and intend to execute their voting rights accordingly. 4. The Notifying Persons do not intend to essentially change the capital structure of the corporation, especially with regards to the ratio of internal/outside financing and the dividend policy. Moreover the Notifying Persons informed us according to section 27a para 1 sentence 1 and 4 of the German Securities Trading Act with respect to the origin of the used funds for the acquisition of the voting rights, that: The Notifying Persons financed the acquisition by own funds. Bad Neustadt a. d. Saale, 22 December 2014 The Board of Management Dr. Kai G. Klinger SVP - Investor Relations, Corporate Finance and M&A RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736 22.12.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÃN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: RHÃN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
| Source: EQS Group AG